Business
Metall Zug Group – result for the 2024 financial year
Metall Zug Group – result for the 2024 financial
About this update from Metall Zug Ag Class B
[{"type":"text","content":"\nMetall Zug AG / Key word(s): Annual Results\n\nMetall Zug Group – result for the 2024 financial year \n24-March-2025 / 06:25 CET/CEST\n\nRelease of an ad hoc announcement pursuant to Art. 53 LR\n\nThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 Listing Rules of SIX Swiss ExchangeZug, March 24, 2025 – Metall Zug (SIX: METN) announces result for the 2024 financial year Successful start of joint venture SteelcoBelimed with positive net result in the first year; transaction led to gain of CHF 66.6 million\n\tHaag-Streit product offensive launched with the introduction of the new Metis surgical microscope\n\tStrategic focus on ophthalmology supported by the proposal to elect Sandrine Zweifel, Deputy Head of the Ophthalmology Clinic at the University Hospital of Zurich, as new member of the Board of Directors\n\tNet sales of CHF 283.4 million (2023: CHF 494.7 million); divestment effect Belimed CHF -166.4 million; negative FX effect -0.8%; organic decrease -8.3%\n\tEBIT CHF 58.0 million (2023: CHF 30.1 million), including gain from the combination of Belimed with Steelco of CHF 66.6 million and proportional net result from strategic investments of CHF 3.1 million (2023: CHF 17.0 million)\n\tDividend proposal: CHF 2.00 per type A registered share and CHF 20.00 per type B registered share Metall Zug GroupThe Metall Zug Group achieved a significant milestone in its strategic transformation with the successful completion of the joint venture with Miele in June 2024, allowing the newly formed SteelcoBelimed to commence operations. SteelcoBelimed is the number three provider of washers and sterilizers in the global market and targets an EBIT margin of 10% in the medium term. Metall Zug will remain invested in the combined company and holds a 33% stake. \n\n “At Haag-Streit, we are seeing the first promising results of our investments in new products and innovations.” Matthias Rey, CEO of Metall Zug AG \n\n \n\nAt Haag-Streit, the systematically increased investments in R&D in recent years bear fruits and allowed Haag-Streit to successfully launch two new products in 2024 – the IM 910 – 3D imaging module and the new high-quality surgical microscope Metis. Metis will enable Haag-Streit to remain a strong player in ophthalmic surgery. As a result of the o...